Minerva Surgical, Inc. (UTRS)

Market Cap	9.00
Revenue (ttm)	51.69M
Net Income (ttm)	-33.45M
Shares Out	8.88M
EPS (ttm)	-5.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	285
Open	n/a
Previous Close	0.0001
Day's Range	n/a
52-Week Range	0.0000 - 6.1600
Beta	4.58
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Minerva Surgical

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure moni...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 174
• Stock Exchange: OTCMKTS
• Ticker Symbol: UTRS

Financial Performance

In 2022, Minerva Surgical's revenue was $50.29 million, a decrease of -3.47% compared to the previous year's $52.10 million. Losses were -$34.11 million, 58.9% more than in 2021.